Reported Aug 25, 2021 · Terminated
Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only, Mfd By: Dr. Reddy's Laboratories limited, Srikakulam…
Dr. Reddy's Laboratories, Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Dr. Reddy's Laboratories, Inc. · 107 College Rd E · Princeton, NJ · 08540-6623
Is this the product you have?
- Tizanidine HCl Tablets, USP 4 mg, 150-count bottles, Rx only
- Mfd ByDr. Reddy's Laboratories limited, Srikakulam District, 532 409 INDIA, NDC 55111-180-15
- Lot codes and dates
Lot #: T2000471exp date 09/2023
- Amount recalled
- 37560 bottles
Where it was sold
- Nationwide
Why it was recalled
Failed Tablet/Capsule Specification: Some tablets are shaved
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Dr. Reddy's Laboratories, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.